Content by Neurogene Inc.
|2 min read
First Two Children Receive New Gene Therapy for Rett Syndrome
Phase 1/2 trial showed the safety and therapeutic potential of administering a novel transgene
Page 1 of 1
Phase 1/2 trial showed the safety and therapeutic potential of administering a novel transgene